The effect of high-polyphenol olive oil in cardiovascular risk markers in healthy adults
- Conditions
- Cardiovascular diseaseMild cognitive declineCardiovascular - Coronary heart diseaseNeurological - Studies of the normal brain and nervous system
- Registration Number
- ACTRN12618000706279
- Lead Sponsor
- a Trobe University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 50
Aged 18-75 years
The exclusion criteria of Post and peri-menopausal women has been removed. More specifically the updated list of the key exclusion criteria is as follows:
Non-English-speaking persons
• Pregnant or lactating women
• History of adverse reactions to olive oil (
• Currently prescribed warfarin, anti-coagulant therapy, statin medications, all oral hypoglycaemic agents, insulin, cyclosporine, tacrolimus, immunosuppressant agents, antihypertensive agents, and nonsteroidal anti-inflammatory drugs (hypothesised interactions), hormone replacement therapy
• A habitual diet with greater than or equal to 1 tablespoon of olive oil per day;
• Current smoker;
• Use of antioxidant supplements or medications with antioxidant properties,
• Diagnosed with any of the following conditions: hyperlipidaemia; diabetes mellitus; hypertension; inflammatory conditions (e.g. rheumatoid arthritis), intestinal disease (e.g. inflammatory bowel disease); irritable bowel syndrome, food intolerances, blood coagulation disorders, or any other physiological condition or disease that could impair adherence.
-Unstable body weight within =/>5kg weight fluctuations in the prior 3 months
-Special diet for medical reasons (i.e gluten free for coeliac disease)
Exclusion criteria for cognition component only.
-Currently prescribed antidepressant medication
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method